TECFIDERA (dimethyl fumarate) data reinforce strong, sustained efficacy for newly-diagnosed MS patients

Biogen has announced new data that continue to support TECFIDERA® (dimethyl fumarate) as an effective, long-term treatment for people who are living with relapsing forms of multiple...